July 2020 Clinical Watch Newsletter

August 4, 2020

In this issue of Clinical Watch, we discuss new antipsychotic medication formulations to tailor the management of schizophrenia and suggest prior authorization criteria for a new treatment for Cushing’s disease. Lastly, we review claims data to identify the trends for use of Dupixent®.
For more information about a topic, please contact Janelle Sheen, Karen Powell or Mary-Beth Plum. Be sure to watch for future monthly updates. For more information about our solutions, please visit conduent.com/pharmacysolutions.

Previous Flipbook
Everest Group PEAK Matrix® for Customer Experience Management (CXM) Service Providers 2020
Everest Group PEAK Matrix® for Customer Experience Management (CXM) Service Providers 2020

Next Flipbook
June 2020 Clinical Watch Newsletter
June 2020 Clinical Watch Newsletter

In this issue of Clinical Watch, we discuss nitrosamine impurities found in widely used medications and sug...